Fatal Gastrointestinal Mucormycosis in Infant Following Ingestion of Contaminated Dietary Supplement
Date Sent: 11/25/2014 04:38 PM EST
Sender: Michigan Health Alert Network
Subject: Fatal Gastrointestinal Mucormycosis in Infant Following Ingestion of Contaminated Dietary Supplement
The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and Connecticut Departments of Public Health and Consumer Protection are investigating a fatal case of gastrointestinal (GI) mucormycosis caused by Rhizopus oryzae in a premature infant. The infant received ABC Dophilus(R) Powder, a dietary supplement product containing viable microbial ingredients purchased from Solgar, Inc., Leonia, New Jersey. The product claimed to have "probiotic" properties and is marketed for infants and children. Subsequent testing of the same lot of unopened Solgar ABC Dophilus(R) Powder revealed contamination with Rhizopus oryzae.
Additional information is attached to this Alert and posted in the Michigan Health Alert Network (MIHAN) Document Library.
(This message was distributed to: The CD / IC Role, Local Public Health Emergency Preparedness Coordinators, Health Officers, Regional Epi's, Regional Health Coalitions and OPHP)